News | December 15, 2010

aycan, Definiens Partner to Market Lung Tumor Detection Solution


December 15, 2010 – Definiens and aycan have formed a partnership to complete the first joint project to quantify and analyze lung tumors.

Under the partnership, Definiens has combined its LungExpert with aycan’s OsiriX PRO to create a workstation that quantifies lung tumors according to RECIST and WHO guidelines and also by their volume. This new integrated solution enables efficient analysis of lesions, including automated quantification of lung tumors.

The new workstation is expected to be available in early 2011.

For more information: www.aycan.com, www.definiens.com

Related Content

The study, led by principal investigator Nitin Ohri, M.D., a professor in Radiation Oncology at the Montefiore Einstein Comprehensive Cancer Center, aims to demonstrate the feasibility of PGHD collection during proton beam radiotherapy for lung cancer
News | Proton Therapy
Koneksa Announces Study with New York Proton Center to Collect Patient-Generated Health Data During Proton Radiotherapy in Lung Cancer

April 29, 2024 — Koneksa, a healthcare technology company pioneering evidence-based digital biomarkers, announced today ...

Time April 29, 2024
arrow
Artificial intelligence can spot COVID-19 in lung ultrasound images much like facial recognition software can spot a face in a crowd, new research shows.
News | Coronavirus (COVID-19)
AI Can Now Detect COVID-19 in Lung Ultrasound Images

March 21, 2024 — Artificial intelligence can spot COVID-19 in lung ultrasound images much like facial recognition ...

Time March 21, 2024
arrow
NIH supported study shows that the virus that causes COVID-19 can damage the heart without directly infecting heart tissue.
News | Coronavirus (COVID-19)
Severe Lung Infection During COVID-19 Can Cause Damage to the Heart

March 20, 2024 — SARS-CoV-2, the virus that causes COVID-19, can damage the heart even without directly infecting the ...

Time March 20, 2024
arrow
Body Vision Medical announced the successful validation of Body Vision's LungVision system with Fujifilm Healthcare Americas Corporation's Persona line of C-arms and FDR Cross two-in-one fluoroscopy C-arm and portable digital radiography solution
News | Artificial Intelligence
Body Vision Medical Announces Successful Validation of LungVision System with Fujifilm's Range of Surgical C-arms

March 6, 2024 — Body Vision Medical, a leader in AI-driven, intraoperative imaging, announced the successful validation ...

Time March 06, 2024
arrow
AIxSCAN, Inc. has issued an update on its plans to produce over 50 lung disease patients scans with its ARC60, an AI-based tomosynthesis X-ray imaging system ahead of requesting 510k U.S. Food and Drug Administration (FDA) approval in 2024.
News | Artificial Intelligence
AIxSCAN Issues Update on 2024 Plans for Lung Scans with AI-driven ARC60 Tomosynthesis X-ray Imaging System

February 29, 2024 — AIxSCAN, Inc., a Sunnyvale, CA-based developer of a next generation artificial intelligence (AI) ...

Time February 29, 2024
arrow
DeepHealth is a global leader in providing AI-powered radiology and health informatics for real-world clinical settings and large-scale screening programs
News | Artificial Intelligence
DeepHealth to Present Latest Results from AI-powered Screening and Diagnostic Programs at the European Congress of Radiology 2024

February 26, 2024 — DeepHealth, Inc., one of the leading providers in healthcare radiology informatics, has today ...

Time February 26, 2024
arrow
ResMD’s enterprise image and document viewing solution provides one simple interface for healthcare professionals across the globe to securely access patient imaging. John W. Ayers, Ph.D., is deputy director of informatics in Altman Clinical and Translational Research Institute and a Qualcomm Institute affiliate at University of California, San Diego. Image courtesy of Qualcomm Institute at UC San Diego
News | Radiology Business
Banyan Software Acquires ResolutionMD from Calgary Scientific, Inc.

February 1, 2024 — Banyan Software, a leading acquirer and permanent home for great software businesses, announces the ...

Time February 01, 2024
arrow
The U.S. Department of Veterans Affairs has selected Riverrain’s ClearRead CT AI-powered technology as part of its Lung Precision Oncology Program.
News | Artificial Intelligence
AI-Powered CT Technology to Help Veterans

February 1, 2024 — Nearly 8,000 veterans are diagnosed with lung cancer each year. Now at-risk veterans will have access ...

Time February 01, 2024
arrow
LungQ 3.0.0 builds on 10 years of clinical trials and 200+ publications to deliver advanced segmentation of pulmonary segments and subsegments
News | Artificial Intelligence
Thirona receives FDA 510(k) Clearance for LungQ v3.0.0 Software to Power AI Analysis of Chest CT Images

January 22, 2024 — Thirona, a global company specializing in advanced analysis of thoracic CT images with artificial ...

Time January 22, 2024
arrow
Artificial intelligence in oncology uses deep learning algorithms to analyze medical images and genomic data to detect cancer at an early stage, predict patient outcomes, and personalize treatment plans. It helps radiologists in diagnosing cancer accurately by analyzing medical images.
Feature | Artificial Intelligence
Artificial Intelligence in Oncology Market to Hit $9.16 Billion by 2031, Per New Report

Coherent Market Insights has recently published a report, titled, Artificial Intelligence in Oncology Market, By ...

Time January 12, 2024
arrow
© Copyright Wainscot Media. All Rights Reserved.
Subscribe Now